Literature DB >> 23805605

Diagnostic criteria for major depressive disorder in cancer patients: a review.

Ng Chong Guan1, Ahmad Hatim Sulaiman, Nor Zuraida Zainal, Marco P M Boks, Niek J De Wit.   

Abstract

OBJECTIVES: The lack of universal criteria makes diagnosing clinical depression in cancer patients a challenging task. We therefore review the current state of evidence regarding such diagnostic criteria for major depressive disorder in cancer patients.
METHODS: We conducted a literature search for studies which compare two or more sets of diagnostic criteria for depression in cancer patients. The results were extracted and summarized.
RESULTS: Three original studies were included in this review. One study supported the use of substitutive (Endicott) criteria. Another study showed the potential of an increased threshold approach and one had no conclusive findings.
CONCLUSION: There was no standard reference test and precise definition of alternative criteria in these studies. There are no recognized diagnostic criteria for depression in cancer patients despite an apparent need for such criteria.

Entities:  

Mesh:

Year:  2013        PMID: 23805605     DOI: 10.2190/PM.45.1.f

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  3 in total

1.  Patterns and predictors of antidepressant use in ambulatory cancer patients with common solid tumors.

Authors:  Michael J Fisch; Fengmin Zhao; Judith Manola; Andrew H Miller; William F Pirl; Lynne I Wagner
Journal:  Psychooncology       Date:  2014-06-14       Impact factor: 3.894

2.  Depression and Anxiety Disorders among Hospitalized Women with Breast Cancer.

Authors:  Neomi Vin-Raviv; Tomi F Akinyemiju; Sandro Galea; Dana H Bovbjerg
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

Review 3.  Depressive Spectrum Disorders in Cancer: Diagnostic Issues and Intervention. A Critical Review.

Authors:  Rosangela Caruso; Maria GiuliaNanni; Michelle B Riba; Silvana Sabato; Luigi Grassi
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.